Kezar Life Sciences, Inc. - COM (KZR)

Historical Portfolio Holders from Q2 2018 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
37.4M
Holdings value Q3 2024
$28.9M
Value change Q3 2024
+$901K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
54
Number of buys Q3 2024
17
Number of sells Q3 2024
-43
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 37.4M $28.9M +$901K $0.77 54
2024 Q2 39.4M $23.6M -$4M $0.60 76
2024 Q1 44.7M $40.3M -$4.36M $0.90 80
2023 Q4 49.4M $46.8M -$6.02M $0.95 81
2023 Q3 55.5M $66M -$2.95M $1.19 81
2023 Q2 56.8M $139M -$10.7M $2.45 101
2023 Q1 60.1M $188M -$2.11M $3.13 136
2022 Q4 57.3M $403M -$11.1M $7.04 120
2022 Q3 57.4M $495M +$24.1M $8.61 128
2022 Q2 54.8M $453M +$61.4M $8.27 125
2022 Q1 44.1M $732M +$63.9M $16.62 120
2021 Q4 39.3M $657M +$202M $16.72 103
2021 Q3 28.1M $243M +$7.81M $8.64 75
2021 Q2 27.6M $150M +$4.15M $5.43 73
2021 Q1 26.5M $157M +$18.3M $5.96 79
2020 Q4 23.5M $123M +$1.91M $5.22 75
2020 Q3 23.2M $112M -$610K $4.84 76
2020 Q2 23.2M $120M +$25.8M $5.18 84
2020 Q1 18.5M $80.6M +$40.7M $4.36 58
2019 Q4 9.17M $36.8M -$693K $4.01 54
2019 Q3 9.42M $30.9M -$5.44M $3.28 53
2019 Q2 10M $77.2M +$5.81M $7.71 53
2019 Q1 9.92M $176M +$12.2M $17.74 50
2018 Q4 9.34M $220M +$7.17M $23.60 40
2018 Q3 9.05M $194M +$21.7M $21.41 37
2018 Q2 8.16M $141M +$141M $17.30 27